16350721

Jakubowski L

2005

[Genetic aspects of polycystic ovary syndrome].

16350724

Kacalska O

2005

[Molecular action of insulin-sensitizing agents].

16352680

Eisenhardt S

2006

Early effects of metformin in women with polycystic ovary syndrome: a prospective randomized, double-blind, placebo-controlled trial.

16353672

Lee CH

2005

The effect of testosterone supplement on insulin sensitivity, glucose effectiveness, and acute insulin response after glucose load in male type 2 diabetics.

16354894

Rosenfield RL

2005

Clinical practice. Hirsutism.

16355019

Sartor BM

2005

Polycystic ovarian syndrome and the metabolic syndrome.

16359551

Mavropoulos JC

2005

The effects of a low-carbohydrate, ketogenic diet on the polycystic ovary syndrome: a pilot study.

16359965

Chu MC

2005

M?llerian-inhibiting substance reflects ovarian findings in women with polycystic ovary syndrome better than does inhibin B.

16359966

Cattrall FR

2005

Anatomical evidence for in utero androgen exposure in women with polycystic ovary syndrome.

16359967

Inal MM

2005

Comparison of the clinical efficacy of flutamide and spironolactone plus Diane 35 in the treatment of idiopathic hirsutism: a randomized controlled study.

16359984

Lucidi RS

2005

Effect of chromium supplementation on insulin resistance and ovarian and menstrual cyclicity in women with polycystic ovary syndrome.

16359985

El-Sheikh MM

2005

Oocytes collected 60 hours after human chorionic gonadotropin administration from patients with polycystic ovary syndrome who underwent limited ovarian stimulation resulted in clinical pregnancies and the delivery of a healthy baby.

16360262

Mitkov M

2006

Metformin versus rosiglitazone in the treatment of polycystic ovary syndrome.

16361289

Pillay OC

2006

The association between polycystic ovaries and endometrial cancer.

16364998

Modugno F

2005

Inflammation and endometrial cancer: a hypothesis.

16368745

Pigny P

2006

Serum anti-Mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome.

16369286

Oyawoye OA

2005

Prevention of ovarian hyperstimulation syndrome by early aspiration of small follicles in hyper-responsive patients with polycystic ovaries during assisted reproductive treatment cycles.

16370570

Marcovecchio M

2005

Type 2 diabetes mellitus in children and adolescents.

16373248

Kizkin S

2005

Cerebral artery hemodynamics in polycystic ovary syndrome.

16373249

La Marca A

2005

Does plasma insulin level affect ovarian response to exogenous administration of follicle-stimulating hormone in women without polycystic ovary syndrome?

16373410

Topcu S

2006

Do young women with polycystic ovary syndrome show early evidence of preclinical coronary artery disease?

16373416

Manikkam M

2006

Fetal programming: prenatal testosterone treatment leads to follicular persistence/luteal defects; partial restoration of ovarian function by cyclic progesterone treatment.

16374625

Dieterle C

2006

[Comorbidities and complications of adiposis].

16378358

Meyers L

2005

Women, polycystic ovary syndrome, and type 2--we are family. This sister you never knew you had may be wreaking havoc with your hormone and insulin levels.

16378909

Wild R

2006

Complementary and alternative therapies: the power of randomization.

16378915

Chan CC

2006

Effects of Chinese green tea on weight, and hormonal and biochemical profiles in obese patients with polycystic ovary syndrome--a randomized placebo-controlled trial.

16379571

Kohama T

2005

The effect of soybeans on the anovulatory cycle.

16381363

Tabrizi NM

2005

Comparison of 5-, 10-, and 15-point laparoscopic ovarian electrocauterization in patients with polycystic ovarian disease: a prospective, randomized study.

16382003

Carmina E

2006

Metabolic syndrome in polycystic ovary syndrome (PCOS): lower prevalence in southern Italy than in the USA and the influence of criteria for the diagnosis of PCOS.

16388122

Greiner M

2005

Role of stress and sympathetic innervation in the development of polycystic ovary syndrome.

16390494

Franks S

2006

Development of polycystic ovary syndrome: involvement of genetic and environmental factors.

16390777

Hayashi H

2005

Preoperative luteinizing hormone levels predict the ovulatory response to laparoscopic ovarian drilling in patients with clomiphene citrate-resistant polycystic ovary syndrome.

16390779

Garmes HM

2005

Endocrine-metabolic effects of the treatment with pioglitazone in obese patients with polycystic ovary syndrome.

16390781

Maher JF

2005

FEM1A is a candidate gene for polycystic ovary syndrome.

16390783

Cristello F

2005

Therapeutic strategies for ovulation induction in infertile women with polycystic ovary syndrome.

16391898

Ferk P

2006

No association between the microsatellite polymorphism (TTTTA)n in the promoter of the CYP11A gene and ovarian hyperstimulation syndrome.

16392065

Rudolph J

2006

[Bilateral cystic ovary in an adolescent].

16396936

Gonz?lez A

2006

Specific haplotypes of the CALPAIN-5 gene are associated with polycystic ovary syndrome.

16398450

Ib??ez L

2005

Hyperandrogenism and excess weight gain.

16401000

Stiefelhagen P

2005

[Rare diabetes etiologies. Unhealthy life style is not always at fault].

16407452

Ib??ez L

2006

Low-dose flutamide-metformin therapy for hyperinsulinemic hyperandrogenism in non-obese adolescents and women.

16408139

Shapiro J

2005

Treatments for unwanted facial hair.

16409817

Li X

2005

[Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].

16409859

Wang Y

2005

[Microsatellite polymorphism of (tttta) n in the promoter of CYP11a gene in Chinese women with polycystic ovary syndrome].

16410336

Vambergue A

2006

Follow-up study of two sisters with type A syndrome of severe insulin resistance gives a new insight into PCOS pathogenesis in relation to puberty and pregnancy outcome: a case report.

16412756

Allemand MC

2006

Diagnosis of polycystic ovaries by three-dimensional transvaginal ultrasound.

16412759

Boothroyd C

2006

Higher-order multiple pregnancy associated with metformin in women with polycystic ovary syndrome: two cases and review of the literature.

16412762

Bentov Y

2006

Cullen's sign following ultrasound-guided transvaginal oocyte retrieval.

16412768

Shibahara H

2006

Postoperative endocrine alterations and clinical outcome of infertile women with polycystic ovary syndrome after transvaginal hydrolaparoscopic ovarian drilling.

16417732

Mulders AG

2005

Influence of oral contraceptive pills on phenotype expression in women with polycystic ovary syndrome.

16418209

Franks S

2006

Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: in defense of the Rotterdam criteria.

16418211

Azziz R

2006

Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature.

16418696

Charles B

2006

Population pharmacokinetics of metformin in late pregnancy.

16419490

Doi SA

2005

Ovarian steroids modulate neuroendocrine dysfunction in polycystic ovary syndrome.

16423836

Ferrero S

2006

Total and active ghrelin levels in women with polycystic ovary syndrome.

16433936

Lane DE

2006

Polycystic ovary syndrome and its differential diagnosis.

16434451

Lo JC

2006

Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome.

16434454

Pag?n YL

2006

Inverse relationship between luteinizing hormone and body mass index in polycystic ovarian syndrome: investigation of hypothalamic and pituitary contributions.

16434463

Mai K

2006

Free fatty acids increase androgen precursors in vivo.

16435040

Rager KM

2006

Androgen excess disorders in women: the severe insulin-resistant hyperandrogenic syndrome, HAIR-AN.

16439501

Fleming R

2006

Dynamics of FSH-induced follicular growth in subfertile women: relationship with age, insulin resistance, oocyte yield and anti-Mullerian hormone.

16439507

Babayof R

2006

Serum inhibin A, VEGF and TNFalpha levels after triggering oocyte maturation with GnRH agonist compared with HCG in women with polycystic ovaries undergoing IVF treatment: a prospective randomized trial.

16439840

Arslanian SA

2005

Clamp techniques in paediatrics: what have we learned?

16443506

Chakrabarty S

2006

Ovarian dysfunction in peripubertal hyperinsulinemia.

16443877

Baillargeon JP

2006

Altered D-chiro-inositol urinary clearance in women with polycystic ovary syndrome.

16443923

Brown FM

2006

Metformin in pregnancy: its time has not yet come.

16444023

Sharabidze N

2005

Proliferation and apoptosis in ovarian stromal hyperplasia and hyperthecosis.

16444364

Spritzer PM

2005

[Polycystic ovary syndrome associated neoplasms].

16444867

Sydow K

2005

Insulin resistance: potential role of the endogenous nitric oxide synthase inhibitor ADMA.

16449310

Costello MF

2006

A systematic review and meta-analysis of randomized controlled trials on metformin co-administration during gonadotrophin ovulation induction or IVF in women with polycystic ovary syndrome.

16449341

Leibel NI

2006

Relationship of adolescent polycystic ovary syndrome to parental metabolic syndrome.

16451377

Goldie MP

2005

Diabetes in women.

16452543

Hahn S

2006

Decreased soluble leptin receptor levels in women with polycystic ovary syndrome.

16452544

M?hlig M

2006

Predictors of abnormal glucose metabolism in women with polycystic ovary syndrome.

16454570

Talmon GA

2006

A cystic mass in a young woman with presumed polycystic ovarian syndrome. Gynandroblastoma.

16454932

Marikinti K

2006

Unusual presentation of a woman with polycystic ovaries and complex endometrial pathology.

16456339

Olivennes F

2006

The use of gonadotropin-releasing hormone antagonist in ovarian stimulation.

16459352

Elsenbruch S

2006

Determinants of emotional distress in women with polycystic ovary syndrome.

16459463

Andiran N

2005

Global fibrinolytic capacity is decreased in girls with premature adrenarche: a new pathological finding?

16460870

Panidis D

2006

Indices of insulin sensitivity, beta cell function and serum proinsulin levels in the polycystic ovary syndrome.

16460956

Wickenheisser JK

2006

Human ovarian theca cells in culture.

16461681

Yoshida K

2006

Genetic modification of Bacillus subtilis for production of D-chiro-inositol, an investigational drug candidate for treatment of type 2 diabetes and polycystic ovary syndrome.

16461952

Marshall JC

2006

Obesity in adolescent girls: is excess androgen the real bad actor?

16464947

Gonz?lez F

2006

Increased activation of nuclear factor kappaB triggers inflammation and insulin resistance in polycystic ovary syndrome.

16473000

Petry CJ

2006

Associations between common variation in the aromatase gene promoter region and testosterone concentrations in two young female populations.

16475928

Hansen JB

2006

Towards selective Kir6.2/SUR1 potassium channel openers, medicinal chemistry and therapeutic perspectives.

16478764

Sohrabvand F

2006

Efficacy of combined metformin-letrozole in comparison with metformin-clomiphene citrate in clomiphene-resistant infertile women with polycystic ovarian disease.

16479139

Misugi T

2006

Insulin-lowering agents inhibit synthesis of testosterone in ovaries of DHEA-induced PCOS rats.

16483177

Hohmann FP

2005

LH suppression following different low doses of the GnRH antagonist ganirelix in polycystic ovary syndrome.

16483179

Yilmaz M

2005

The effects of rosiglitazone and metformin on insulin resistance and serum androgen levels in obese and lean patients with polycystic ovary syndrome.

16483878

Glueck CJ

2006

Plasminogen activator inhibitor activity, 4G5G polymorphism of the plasminogen activator inhibitor 1 gene, and first-trimester miscarriage in women with polycystic ovary syndrome.

16484974

Novi RF

2002

[Management of overweight and obese patient. New acquisition].

16485627

Paul S

2005

The metabolic syndrome in women: a growing problem for cardiac risk.

16487597

Klipstein KG

2006

Screening for bipolar disorder in women with polycystic ovary syndrome: a pilot study.

16489319

Reaven GM

2005

Insulin resistance, the insulin resistance syndrome, and cardiovascular disease.

16489320

Tan S

2005

Insulin resistance syndrome and polycystic ovary syndrome: implications for diagnosis and treatment.

16492202

Hawthorne G

2006

Metformin use and diabetic pregnancy-has its time come?

16492691

Setji TL

2006

Nonalcoholic steatohepatitis and nonalcoholic Fatty liver disease in young women with polycystic ovary syndrome.

16492701

McCartney CR

2006

The association of obesity and hyperandrogenemia during the pubertal transition in girls: obesity as a potential factor in the genesis of postpubertal hyperandrogenism.

16497098

Baravalle C

2007

The role of ACTH in the pathogenesis of polycystic ovarian syndrome in rats: hormonal profiles and ovarian morphology.